Main Line Retirement Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$339K Buy
1,334
+2
+0.2% +$466 0.16% 38
2026
Q1
$326K Buy
1,332
+3
+0.2% +$699 0.16% 36
2025
Q4
$275K Buy
1,329
+7
+0.5% +$1.38K 0.14% 38
2025
Q3
$245K Buy
1,322
+8
+0.6% +$1.37K 0.13% 40
2025
Q2
$201K Sell
1,314
-156
-11% -$24K 0.11% 42
2025
Q1
$244K Buy
1,470
+8
+0.5% +$1.25K 0.16% 37
2024
Q4
$211K Sell
1,462
-7
-0.5% -$1.08K 0.14% 40
2024
Q3
$238K Buy
1,469
+7
+0.5% +$1.11K 0.16% 32
2024
Q2
$214K Sell
1,462
-63
-4% -$9.37K 0.16% 32
2024
Q1
$241K Buy
1,525
+77
+5% +$12.3K 0.19% 32
2023
Q4
$227K Buy
+1,448
New +$222K 0.2% 34
2023
Q2
$207K Buy
+1,249
New +$202K 0.19% 30

Other funds holding JNJ

Main Line Retirement Advisors's JNJ Position: Q2 2026 in Review

Main Line Retirement Advisors increased its Johnson & Johnson (JNJ) stake by 0.15% in Q2 2026, buying an estimated $466 and bringing the position to 1,334 shares worth $339K. The position accounts for 0.16% of the portfolio, ranked #38.

Main Line Retirement Advisors first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Main Line Retirement Advisors held 1,334 shares of Johnson & Johnson worth $339K as of Q2 2026.
  • Main Line Retirement Advisors bought 2 Johnson & Johnson shares in Q2 2026, an estimated $466.
  • Johnson & Johnson made up 0.16% of Main Line Retirement Advisors's portfolio in Q2 2026, its #38 holding.
  • Main Line Retirement Advisors first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Main Line Retirement Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.